サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：慢性眼表面痛の世界市場の規模調査：薬剤クラス別、用途別、エンドユーザー別、地域別予測（2022～2028年）
市場調査レポート
商品コード
1084059

慢性眼表面痛の世界市場の規模調査：薬剤クラス別、用途別、エンドユーザー別、地域別予測（2022～2028年）

Global Chronic Ocular Surface Pain Market Size study, By Drug Class (Antibiotics, Nonsteroidal Anti-Inflammatory, Corticosteroids, Others), By Application, By End-Users, and Regional Forecasts 2022-2028
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
慢性眼表面痛の世界市場の規模調査：薬剤クラス別、用途別、エンドユーザー別、地域別予測（2022～2028年）
出版日: 2022年05月27日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の慢性眼表面痛市場は、2022～2028年の予測期間中に健全な成長率で成長すると予想されています。

細菌性およびウイルス性の眼感染症の流行、高齢者人口の増加、ドライアイの増加、医療費の増加などは、世界中で市場の需要を促進する要因となっています。しかし、発展途上国での熟練した専門家の不足や高度な医療施設の不足が、予測期間における市場の成長を阻害すると予想されます。

当レポートでは、世界の慢性眼表面痛市場について調査分析し、市場力学、業界分析、薬剤クラス・用途・エンドユーザー・地域別市場分析、企業プロファイルに関する情報を提供してます。

目次

第1章 エグゼクティブサマリー

第2章 世界の慢性眼表面痛市場の定義と範囲

第3章 世界の慢性眼表面痛：市場力学

  • 慢性眼表面痛市場の影響分析（2020～2028年）

第4章 世界の慢性眼表面痛市場：業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 主要投資機会
  • 主要ウィニング戦略

第5章 リスク評価：COVID-19の影響

    • 業界に対するCOVID-19の全体的な影響の評価
    • COVID-19前およびCOVID-19後の市場シナリオ

第6章 世界の慢性眼表面痛市場：薬剤クラス別

  • 市場スナップショット
  • 薬剤クラス、パフォーマンス別-潜在的な分析
  • 市場の推定と予測：薬剤クラス別（2018～2028年（100万米ドル））
  • サブセグメント分析
    • 抗生物質
    • 非ステロイド性抗炎症薬（NSAID）
    • コルチコステロイド
    • その他

第7章 世界の慢性眼表面痛市場：用途別

  • 市場スナップショット
  • 用途、パフォーマンス別-潜在的な分析
  • 市場の推定と予測：用途別（2018～2028年（100万米ドル））
  • サブセグメント分析
    • 副鼻腔炎
    • 偏頭痛
    • 緑内障
    • その他

第8章 世界の慢性眼表面痛市場：エンドユーザー別

  • 市場スナップショット
  • エンドユーザー、パフォーマンス別-潜在的な分析
  • 市場の推定と予測：エンドユーザー別（2018～2028年（100万米ドル））
  • サブセグメント分析
    • 病院
    • 専門クリニック
    • ホームケア
    • その他

第9章 世界の慢性眼表面痛市場：地域分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカスナップショット
    • ブラジル
    • メキシコ
  • その他の地域

第10章 競合情報

  • 主要市場戦略
  • 企業プロファイル
    • Pfizer Inc.
    • Novartis AG
    • Zydus Cadila
    • AstraZeneca
    • Johnson & Johnson
    • Bayer AG
    • Sun Pharmaceutical Industries Ltd.
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • LEO Pharma A/S

第11章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Chronic Ocular Surface Pain Market, report scope
  • TABLE 2. Global Chronic Ocular Surface Pain Market estimates & forecasts by Region 2018-2028 (USD Million)
  • TABLE 3. Global Chronic Ocular Surface Pain Market estimates & forecasts by Drug Class 2018-2028 (USD Million)
  • TABLE 4. Global Chronic Ocular Surface Pain Market estimates & forecasts by Application 2018-2028 (USD Million)
  • TABLE 5. Global Chronic Ocular Surface Pain Market estimates & forecasts by End-Users 2018-2028 (USD Million)
  • TABLE 6. Global Chronic Ocular Surface Pain Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 7. Global Chronic Ocular Surface Pain Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 8. Global Chronic Ocular Surface Pain Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 9. Global Chronic Ocular Surface Pain Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 10. Global Chronic Ocular Surface Pain Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 11. Global Chronic Ocular Surface Pain Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 12. Global Chronic Ocular Surface Pain Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 13. Global Chronic Ocular Surface Pain Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 14. Global Chronic Ocular Surface Pain Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 15. Global Chronic Ocular Surface Pain Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 16. U.S. Chronic Ocular Surface Pain Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 17. U.S. Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 18. U.S. Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 19. Canada Chronic Ocular Surface Pain Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 20. Canada Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 21. Canada Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 22. UK Chronic Ocular Surface Pain Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 23. UK Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 24. UK Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 25. Germany Chronic Ocular Surface Pain Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 26. Germany Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 27. Germany Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 28. RoE Chronic Ocular Surface Pain Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 29. RoE Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 30. RoE Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 31. China Chronic Ocular Surface Pain Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 32. China Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 33. China Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 34. India Chronic Ocular Surface Pain Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 35. India Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 36. India Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 37. Japan Chronic Ocular Surface Pain Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 38. Japan Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 39. Japan Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 40. RoAPAC Chronic Ocular Surface Pain Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 41. RoAPAC Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 42. RoAPAC Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 43. Brazil Chronic Ocular Surface Pain Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 44. Brazil Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 45. Brazil Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 46. Mexico Chronic Ocular Surface Pain Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 47. Mexico Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 48. Mexico Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 49. RoLA Chronic Ocular Surface Pain Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 50. RoLA Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 51. RoLA Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 52. Row Chronic Ocular Surface Pain Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 53. Row Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 54. Row Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 55. List of secondary sources, used in the study of global Chronic Ocular Surface Pain Market
  • TABLE 56. List of primary sources, used in the study of global Chronic Ocular Surface Pain Market
  • TABLE 57. Years considered for the study
  • TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Chronic Ocular Surface Pain Market, research methodology
  • FIG 2. Global Chronic Ocular Surface Pain Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Chronic Ocular Surface Pain Market, key trends 2021
  • FIG 5. Global Chronic Ocular Surface Pain Market, growth prospects 2022-2028
  • FIG 6. Global Chronic Ocular Surface Pain Market, porters 5 force model
  • FIG 7. Global Chronic Ocular Surface Pain Market, pest analysis
  • FIG 8. Global Chronic Ocular Surface Pain Market, value chain analysis
  • FIG 9. Global Chronic Ocular Surface Pain Market by segment, 2018 & 2028 (USD Million)
  • FIG 10. Global Chronic Ocular Surface Pain Market by segment, 2018 & 2028 (USD Million)
  • FIG 11. Global Chronic Ocular Surface Pain Market by segment, 2018 & 2028 (USD Million)
  • FIG 12. Global Chronic Ocular Surface Pain Market by segment, 2018 & 2028 (USD Million)
  • FIG 13. Global Chronic Ocular Surface Pain Market by segment, 2018 & 2028 (USD Million)
  • FIG 14. Global Chronic Ocular Surface Pain Market, regional snapshot 2018 & 2028
  • FIG 15. North America Chronic Ocular Surface Pain Market 2018 & 2028 (USD Million)
  • FIG 16. Europe Chronic Ocular Surface Pain Market 2018 & 2028 (USD Million)
  • FIG 17. Asia Pacific Chronic Ocular Surface Pain market 2018 & 2028 (USD Million)
  • FIG 18. Latin America Chronic Ocular Surface Pain Market 2018 & 2028 (USD Million)
  • FIG 19. Global Chronic Ocular Surface Pain Market, company market share analysis (2021)
目次

Global Chronic Ocular Surface Pain Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Chronic Ocular Surface Pain is a condition that occurs due to the damage of tissue at the ocular surface or from variations to central or peripheral nerves in the ocular surface sensory pathway. The rising prevalence of bacterial and viral ocular infections, increasing geriatric populations, and growing incidences of dry eyes among people, coupled with the rise in healthcare expenditure are several factors fostering the market demand across the globe. For instance, according to the World Health Organization (WHO), the geriatric population around the world is estimated to be over 524 million in 2010, and it is projected to increase to nearly 2 billion by 2050. Consequentially, aged people are more prone to suffer from various eye disorders, which, in turn, augment the market growth across the globe. However, the shortage of skilled professionals and the unavailability of advanced healthcare facilities in developing economies impede the growth of the market over the forecast period of 2022-2028. Also, a rise in the number of research and development activities and increasing drug approvals and launches are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Chronic Ocular Surface Pain Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the increasing technological developments in diagnostic procedures and growing healthcare expenditure. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the rising prevalence of ocular diseases, as well as, rising presence of major generic manufacturers, would create lucrative growth prospects for the Chronic Ocular Surface Pain Market across the Asia-Pacific region.

Major market players included in this report are:

Pfizer Inc.

Novartis AG

Zydus Cadila

AstraZeneca

Johnson & Johnson

Bayer AG

Sun Pharmaceutical Industries Ltd.

Bristol-Myers Squibb Company

Eli Lilly and Company

LEO Pharma A/S

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:

Antibiotics

Nonsteroidal Anti-Inflammatory (NSAID)

Corticosteroids

Others

By Application:

Sinusitis

Migraines

Glaucoma

Others

By End-Users:

Hospitals

Specialty Clinics

Homecare

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Chronic Ocular Surface Pain Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. Chronic Ocular Surface Pain Market, by Region, 2020-2028 (USD Million)
    • 1.2.2. Chronic Ocular Surface Pain Market, by Drug Class, 2020-2028 (USD Million)
    • 1.2.3. Chronic Ocular Surface Pain Market, by Application, 2020-2028 (USD Million)
    • 1.2.4. Chronic Ocular Surface Pain Market, by End-Users, 2020-2028 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Chronic Ocular Surface Pain Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Chronic Ocular Surface Pain Market Dynamics

  • 3.1. Chronic Ocular Surface Pain Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising prevalence of bacterial and viral ocular infections
      • 3.1.1.2. Growing geriatric populations
    • 3.1.2. Market Challenges
      • 3.1.2.1. Shortage of skilled professionals
      • 3.1.2.2. Unavailability of advanced healthcare facilities in developing economies
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rise in the number of research and development activities
      • 3.1.3.2. Increasing drug approvals and launches

Chapter 4. Global Chronic Ocular Surface Pain Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Chronic Ocular Surface Pain Market, by Drug Class

  • 6.1. Market Snapshot
  • 6.2. Global Chronic Ocular Surface Pain Market by Drug Class, Performance - Potential Analysis
  • 6.3. Global Chronic Ocular Surface Pain Market Estimates & Forecasts by Drug Class, 2018-2028 (USD Million)
  • 6.4. Chronic Ocular Surface Pain Market, Sub Segment Analysis
    • 6.4.1. Antibiotics
    • 6.4.2. Nonsteroidal Anti-Inflammatory (NSAID)
    • 6.4.3. Corticosteroids
    • 6.4.4. Others

Chapter 7. Global Chronic Ocular Surface Pain Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Chronic Ocular Surface Pain Market by Application, Performance - Potential Analysis
  • 7.3. Global Chronic Ocular Surface Pain Market Estimates & Forecasts by Application, 2018-2028 (USD Million)
  • 7.4. Chronic Ocular Surface Pain Market, Sub Segment Analysis
    • 7.4.1. Sinusitis
    • 7.4.2. Migraines
    • 7.4.3. Glaucoma
    • 7.4.4. Others

Chapter 8. Global Chronic Ocular Surface Pain Market, by End-Users

  • 8.1. Market Snapshot
  • 8.2. Global Chronic Ocular Surface Pain Market by End-Users, Performance - Potential Analysis
  • 8.3. Global Chronic Ocular Surface Pain Market Estimates & Forecasts by End-Users, 2018-2028 (USD Million)
  • 8.4. Chronic Ocular Surface Pain Market, Sub Segment Analysis
    • 8.4.1. Hospitals
    • 8.4.2. Specialty Clinics
    • 8.4.3. Homecare
    • 8.4.4. Others

Chapter 9. Global Chronic Ocular Surface Pain Market, Regional Analysis

  • 9.1. Chronic Ocular Surface Pain Market, Regional Market Snapshot
  • 9.2. North America Chronic Ocular Surface Pain Market
    • 9.2.1. U.S. Chronic Ocular Surface Pain Market
      • 9.2.1.1. Drug Class breakdown estimates & forecasts, 2018-2028
      • 9.2.1.2. Application breakdown estimates & forecasts, 2018-2028
      • 9.2.1.3. End-Users breakdown estimates & forecasts, 2018-2028
    • 9.2.2. Canada Chronic Ocular Surface Pain Market
  • 9.3. Europe Chronic Ocular Surface Pain Market Snapshot
    • 9.3.1. U.K. Chronic Ocular Surface Pain Market
    • 9.3.2. Germany Chronic Ocular Surface Pain Market
    • 9.3.3. France Chronic Ocular Surface Pain Market
    • 9.3.4. Spain Chronic Ocular Surface Pain Market
    • 9.3.5. Italy Chronic Ocular Surface Pain Market
    • 9.3.6. Rest of Europe Chronic Ocular Surface Pain Market
  • 9.4. Asia-Pacific Chronic Ocular Surface Pain Market Snapshot
    • 9.4.1. China Chronic Ocular Surface Pain Market
    • 9.4.2. India Chronic Ocular Surface Pain Market
    • 9.4.3. Japan Chronic Ocular Surface Pain Market
    • 9.4.4. Australia Chronic Ocular Surface Pain Market
    • 9.4.5. South Korea Chronic Ocular Surface Pain Market
    • 9.4.6. Rest of Asia Pacific Chronic Ocular Surface Pain Market
  • 9.5. Latin America Chronic Ocular Surface Pain Market Snapshot
    • 9.5.1. Brazil Chronic Ocular Surface Pain Market
    • 9.5.2. Mexico Chronic Ocular Surface Pain Market
  • 9.6. Rest of The World Chronic Ocular Surface Pain Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Pfizer Inc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Novartis AG
    • 10.2.3. Zydus Cadila
    • 10.2.4. AstraZeneca
    • 10.2.5. Johnson & Johnson
    • 10.2.6. Bayer AG
    • 10.2.7. Sun Pharmaceutical Industries Ltd.
    • 10.2.8. Bristol-Myers Squibb Company
    • 10.2.9. Eli Lilly and Company
    • 10.2.10. LEO Pharma A/S

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption